Hospira (HSP) Tops Q4 EPS by 11c

Hospira (NYSE: HSP) reported Q4 EPS of $0.53, $0.11 better than the analyst estimate of $0.42. Revenue for the quarter came in at $1.13 billion versus the consensus estimate of $1.12 billion.

For earnings history and earnings-related data on Hospira (HSP) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Bernstein SocGen Group Upgrades Whitbread PLC. (WTB:LN) (WTBCF) to Market Perform
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance